Shilpa Medicare Limited (IN:SHILPAMED)
:SHILPAMED
Want to see IN:SHILPAMED full AI Analyst Report?
SHILPAMED Stock Chart & Stats
₹319.90
-₹8.10(-0.96%)
At close: 4:00 PM EST
₹319.90
-₹8.10(-0.96%)
Day’s Range― - ―
52-Week Range₹260.00 - ₹580.70
Previous CloseN/A
Volume218.26K
Average Volume (3M)38.83K
Market Cap
₹104.11B
Enterprise Value₹114.20B
Total Cash (Recent Filing)₹535.50M
Total Debt (Recent Filing)₹5.93B
Price to Earnings (P/E)44.4
Beta0.76
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.16%
Share Statistics
EPS (TTM)7.01
Shares Outstanding195,581,820
10 Day Avg. Volume85,780
30 Day Avg. Volume38,829
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)2.63
Price to Sales (P/S)4.43
P/FCF Ratio-90.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.95
Revenue Forecast (FY)₹16.94B
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumConsistent, accelerating revenue growth through FY2026 indicates expanding product adoption and stronger commercial traction across domestic and international markets. Durable top-line momentum supports scale, reinvestment in complex generics/R&D and steadier earnings over the medium term.
Improved Operating And Net MarginsA marked margin recovery and solid EBITDA/EBIT margins in FY2026 reflect better cost absorption and pricing on the firm’s specialty/generic portfolio. Sustained higher operating margins create buffer for investment, support profitability resilience and improve long-term return potential if maintained.
Conservative Leverage ProfileLow debt-to-equity and a strengthening equity base give the company financial flexibility to fund capex, R&D or bolt-on deals without straining solvency. A conservatively levered balance sheet reduces refinancing risk and supports durable investment in manufacturing capacity.
Bears Say
Persistent Negative Free Cash FlowRepeated negative free cash flow, including ~-0.75B in FY2026, means reported profits are not generating surplus cash after investment. Over time this limits capacity to self-fund growth, dividends or debt reduction and raises reliance on external financing.
Weak Operating Cash ConversionOperating cash flow coverage materially below 1.0 signals poor conversion of earnings into available cash. Structurally weak cash conversion increases vulnerability to working capital swings and capital intensity, constraining sustained reinvestment and financial flexibility.
Earnings And Margin VolatilityMeaningful swings in margins and past loss-making years indicate earnings quality and cost structure are not fully stable. Persistent volatility complicates forecasting, raises execution risk for sustaining FY2026 margins, and can impair long-term return consistency.
Shilpa Medicare Limited News
SHILPAMED FAQ
What was Shilpa Medicare Limited’s price range in the past 12 months?
Shilpa Medicare Limited lowest stock price was ₹260.00 and its highest was ₹580.70 in the past 12 months.
What is Shilpa Medicare Limited’s market cap?
Shilpa Medicare Limited’s market cap is ₹104.11B.
When is Shilpa Medicare Limited’s upcoming earnings report date?
Shilpa Medicare Limited’s upcoming earnings report date is Aug 06, 2026 which is in 50 days.
How were Shilpa Medicare Limited’s earnings last quarter?
Shilpa Medicare Limited released its earnings results on May 22, 2026. The company reported ₹3.3 earnings per share for the quarter, the consensus estimate of ₹3.3 by ₹0.
Is Shilpa Medicare Limited overvalued?
According to Wall Street analysts Shilpa Medicare Limited’s price is currently Overvalued.
Does Shilpa Medicare Limited pay dividends?
Shilpa Medicare Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.16%. See more information on Shilpa Medicare Limited dividends here
What is Shilpa Medicare Limited’s EPS estimate?
Shilpa Medicare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shilpa Medicare Limited have?
Shilpa Medicare Limited has 195,581,820 shares outstanding.
What happened to Shilpa Medicare Limited’s price movement after its last earnings report?
Shilpa Medicare Limited reported an EPS of ₹3.3 in its last earnings report, expectations of ₹3.3. Following the earnings report the stock price went up 3.778%.
Which hedge fund is a major shareholder of Shilpa Medicare Limited?
Currently, no hedge funds are holding shares in IN:SHILPAMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shilpa Medicare Limited
Shilpa Medicare Limited, including its various subsidiaries, manufactures and distributes a range of active pharmaceutical ingredients (APIs), intermediate compounds, and finished drug formulations. Operating across India, the United States, Europe, and other international markets, their product lineup encompasses both oncology and non-oncology APIs. The company also innovates with new drug delivery systems, biological products such as peptides, and specialized chemicals. Furthermore, Shilpa Medicare provides contract manufacturing services for diverse dosage forms, including tablets, capsules, liquid and lyophilized injectables, and sterile dry powder injectables. Beyond its pharmaceutical operations, the firm also participates in wind power generation. Founded in 1987, Shilpa Medicare Limited maintains its headquarters in Raichur, India.
Technical Analysis
Akums Drugs and Pharmaceuticals Limited
―
Alembic Pharmaceuticals Limited
―
Caplin Point Laboratories Limited
―
Jubilant Pharmova Limited
―
Strides Pharma Science Ltd
―